Molecular signatures reflecting differentiation status of high-grade astrocytoma identify prognostic subclasses of tumor and delineate a pattern of disease progression

被引：0
|
作者：
Phillips, HS
Kharbanda, S
Soriano, RH
Forrest, WF
Wu, TD
Nigro, J
Willams, PM
Soroceanu, L
Misra, A
Feuerstein, BG
Aldape, KD
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
NEURO-ONCOLOGY | 2005年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
243
引用
收藏
页码：345 / 345
页数：1
相关论文
共 25 条
  • [21] Molecular subtyping and immune-gene signatures identify a subset of clinical T1 high-grade (cT1 HG) and cT2 bladder urothelial carcinoma (UC) as candidates for single-agent immune checkpoint inhibition (ICI)
    Necchi, A.
    Raggi, D.
    Gallina, A.
    Bandini, M.
    Giannatempo, P.
    Marandino, L.
    Colecchia, M.
    Briganti, A.
    Montorsi, F.
    Davicioni, E.
    Lotan, Y.
    Gibb, E.
    ANNALS OF ONCOLOGY, 2020, 31 : S586 - S586
  • [22] Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium
    Jacek Glajzer
    Dan Cacsire Castillo-Tong
    Rolf Richter
    Ignace Vergote
    Hagen Kulbe
    Adriaan Vanderstichele
    Ilary Ruscito
    Fabian Trillsch
    Alexander Mustea
    Caroline Kreuzinger
    Charlie Gourley
    Hani Gabra
    Eliane T. Taube
    Oliver Dorigo
    David Horst
    Carlotta Keunecke
    Joanna Baum
    Timothy Angelotti
    Jalid Sehouli
    Elena Ioana Braicu
    Annals of Surgical Oncology, 2023, 30 : 35 - 45
  • [23] Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium
    Glajzer, Jacek
    Castillo-Tong, Dan Cacsire
    Richter, Rolf
    Vergote, Ignace
    Kulbe, Hagen
    Vanderstichele, Adriaan
    Ruscito, Ilary
    Trillsch, Fabian
    Mustea, Alexander
    Kreuzinger, Caroline
    Gourley, Charlie
    Gabra, Hani
    Taube, Eliane T.
    Dorigo, Oliver
    Horst, David
    Keunecke, Carlotta
    Baum, Joanna
    Angelotti, Timothy
    Sehouli, Jalid
    Braicu, Elena Ioana
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 35 - 45
  • [24] ASO Visual Abstract: Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome, and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer (HGSOC). A Multicenter, Retrospective Study of the Ovarian Cancer Therapy—Innovative Models Prolong Survival (OCTIPS) Consortium
    Jacek Glajzer
    Dan Cacsire Castillo-Tong
    Rolf Richter
    Ignace Vergote
    Hagen Kulbe
    Adriaan Vanderstichele
    Ilary Ruscito
    Fabian Trillsch
    Alexander Mustea
    Caroline Kreuzinger
    Charlie Gourley
    Hani Gabra
    Eliane T. Taube
    Oliver Dorigo
    David Horst
    Carlotta Keunecke
    Joanna Baum
    Timothy Angelotti
    Jalid Sehouli
    Elena Ioana Braicu
    Annals of Surgical Oncology, 2023, 30 : 46 - 47
  • [25] ASO Visual Abstract: Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome, and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer (HGSOC). A Multicenter, Retrospective Study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium
    Glajzer, Jacek
    Castillo-Tong, Dan Cacsire
    Richter, Rolf
    Vergote, Ignace
    Kulbe, Hagen
    Vanderstichele, Adriaan
    Ruscito, Ilary
    Trillsch, Fabian
    Mustea, Alexander
    Kreuzinger, Caroline
    Gourley, Charlie
    Gabra, Hani
    Taube, Eliane T.
    Dorigo, Oliver
    Horst, David
    Keunecke, Carlotta
    Baum, Joanna
    Angelotti, Timothy
    Sehouli, Jalid
    Braicu, Elena Ioana
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 46 - 47
123